To determine whether GIT1 expression could predict prognosis in breast cancer patients, we performed a Kaplan–Meier analysis in multiple databases, which revealed a direct correlation between high GIT1 expression and increased relapse-free survival (Fig. 1f, g). Here, GIT1 is linked to breast cancer.